Viewing Study NCT06308406


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2025-12-29 @ 10:50 AM
Study NCT ID: NCT06308406
Status: RECRUITING
Last Update Posted: 2024-04-11
First Post: 2024-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module